Circassia Pharmaceutical Plc

(CSSPF)

By |

Profile

Circassia Pharmaceuticals PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has three business segments, US AZ collaboration, Respiratory, and NIOX. The clear majority of revenue is generated by sales in the United States and European Union, followed by other international locations. The bulk of revenue is derived from Circassia's NIOX segment, which is focused on the diagnosis and management of asthma. The company sells its NIOX products direct to specialists in the U.S, U.K and Germany, while its partners market them elsewhere.

Contact Information

Website: www.circassia.com
Main Phone: +44 1865405560
Address: Magdalen Centre, Robert Robinson Avenue
Address 2: Northbrook House, Oxford Science Park
State: Oxon
City / Town: Oxford
Country: GBR
Postal Code: OX4 4GA

Issuer Information

Exchange: GREY
CEO: Steven Charles Andrew Harris
Employees: 396
$ 0.90 $ 0. (0.00%)
Last Price 0.90 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.90
Last Trade Volume 0 52 Wk Hi 1.30 52 Wk Low 0.90
Market Cap 321.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 357,303,623.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys